Current Drug Targets - Inflammation & Allergy

Author(s): Rossella Paolini, Michela Armigliato and Sergio Zamboni

DOI: 10.2174/1568010042634613

Cite As
Pulmonary Hypertension and Systemic Diseases

Page: [459 - 467] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.

Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia